Table 1.
Characteristic | Age <45 years | Age ≥45 years | P-value |
---|---|---|---|
(n = 39) | (n = 38) | ||
Age, years | |||
Median | 39 | 65.3 | |
Range | 25–44 | 48–85 | |
Sex | |||
Male | 19 | 20 | 0.731 |
Female | 20 | 18 | |
Tobacco consumption | |||
No | 7 | 7 | 0.904 |
Yes | 29 | 27 | |
Unknown | 3 | 4 | |
Alcohol consumption | |||
No | 17 | 12 | 0.418 |
Yes | 19 | 20 | |
Unknown | 3 | 6 | |
WHO Performance status | |||
0 | 27 | 12 | 0.004 |
1 | 10 | 17 | |
2–3 | 2 | 8 | |
Unknown | 0 | 1 | |
T classification | |||
1 | 7 | 5 | 0.178 |
2 | 11 | 16 | |
3 | 9 | 3 | |
4 | 10 | 14 | |
Unknown | 2 | 0 | |
N classification | |||
0 | 11 | 14 | 0.464 |
1–3 | 27 | 24 | |
Unknown | 1 | 0 | |
M classification | |||
0 | 28 | 33 | not evaluable |
1 | 0 | 0 | |
Unknown | 11 | 5 | |
Anatomic site | |||
Oropharyngeal | 8 | 8 | 0.953 |
Non-oropharyngeal | 31 | 30 | |
Treatment | |||
Surgery | 9 | 13 | 0.279 |
Chemotherapy and/or radiotherapy | 15 | 12 | 0.527 |
Surgery + adjuvant treatment | 15 | 11 | 0.377 |
No treatment | 0 | 2 | 0.240 |
HPV status | |||
HPV16+ | 4 | 5 | 0.967 |
HPV16− | 35 | 33 | |
p16 expression | |||
p16+ | 6 | 4 | 0.768 |
p16− | 33 | 34 |
HPV, human papillomavirus, WHO, World Health Organization.